Dasatinib Synthon 100mg film-coated tablets Мальта - англійська - Medicines Authority

dasatinib synthon 100mg film-coated tablets

synthon bv microweg 22, 6545 cm nijmegen, netherlands - dasatinib - film-coated tablet - dasatinib 100 mg - antineoplastic agents

Dasatinib Synthon 140mg film-coated tablets Мальта - англійська - Medicines Authority

dasatinib synthon 140mg film-coated tablets

synthon bv microweg 22, 6545 cm nijmegen, netherlands - dasatinib - film-coated tablet - dasatinib 140 mg - antineoplastic agents

DASATINIB DR.REDDY'S dasatinib 100 mg film coated tablet blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

dasatinib dr.reddy's dasatinib 100 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 116 mg (equivalent: dasatinib, qty 100 mg) - tablet, film coated - excipient ingredients: hydrogenated castor oil; lactose; silicon dioxide; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.

DASATINIB DR.REDDY'S dasatinib 20 mg film coated tablet blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

dasatinib dr.reddy's dasatinib 20 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 23.2 mg (equivalent: dasatinib, qty 20 mg) - tablet, film coated - excipient ingredients: lactose; croscarmellose sodium; triacetin; hydrogenated castor oil; magnesium stearate; titanium dioxide; silicon dioxide; microcrystalline cellulose; hypromellose - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.